Send the following on WhatsApp
Continue to ChatAurobindo subsidiary gets license to develop and market Nilotinib Capsules in LMICs https://business-news-today.com/aurobindos-eugia-pharma-granted-license-to-develop-and-market-nilotinib-capsules-in-lmics/